Tiziana Life Sciences annual r&d spending
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Tiziana Life Sciences R&D Spending Growth & History (TLSA)
Tiziana Life Sciences's r&d spending was $10.3M for fiscal 2025.
View full Tiziana Life Sciences company overviewTiziana Life Sciences annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $10.3M | $5.0M | +96.58% |
| 2024 | 2024-12-31 | $5.2M | −$2.9M | −35.55% |
| 2023 | 2023-12-31 | $8.1M | −$4.8M | −37.38% |
| 2022 | 2022-12-31 | $13.0M | −$253,000 | −1.92% |
| 2021 | 2021-12-31 | $13.2M | $7.2M | +120.39% |
| 2020 | 2020-12-31 | $6.0M | $2.3M | +61.36% |
| 2019 | 2019-12-31 | $3.7M | −$1.8M | −32.60% |
| 2018 | 2018-12-31 | $5.5M | −$505,000 | −8.40% |
| 2017 | 2017-12-31 | $6.0M | $2.0M | +50.11% |
| 2016 | 2016-12-31 | $4.0M | — | — |
Tiziana Life Sciences r&d spending trends
Over the last five fiscal years, Tiziana Life Sciences's r&d spending increased from $6.0M to $10.3M, a change of $4.3M.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Tiziana Life Sciences source filings ↗